SPRY ARS Pharmaceuticals, Inc.

$4.76▼ -5.93% Healthcare Other
After hours $4.82▲ +1.26% Sep 11, 7:43 PM ET
Volume 2.57M Avg Volume (10D) 1.19M
Key Metrics & Fundamentals
Market Cap
$473.37M
P/E Ratio
–
Div Yield
–%
52W Range
4.73 - 13.15
% vs 50 MA
-23.46%
% vs 200 MA
-44.16%
RSI-14
31.1
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.52
Free Cash Flow
-$60.93M
Gross Rev
$33.66M
Gross Profit
$20.81M
EBITDA
-$59.86M
COGS
$12.85M
Operating Exp
$82.28M
Operating Income
-$61.47M
EBIT
-$61.47M
Pretax Income
-$62.34M
Net Income
-$62.34M
EPS (Diluted)
-0.63
Price & Volume History
Loading chart…
Recent News
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
GlobeNewswire · Sep 1, 2026 8:01 PM
ARS Pharma (SPRY) Cuts Spending As It Chases Neffy Market Share
Insider Monkey · Aug 21, 2026 10:08 PM
Can ARS Pharmaceuticals, Inc. (SPRY) Climb 297.02% to Reach the Level Wall Street Analysts Expect?
Zacks · Aug 20, 2026 1:55 PM
ARS Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 14, 2026 12:30 PM
ARS Pharmaceuticals Inc (SPRY) (Q2 2026) Earnings Call Highlights: Market Share Doubles to 5% ...
GuruFocus.com · Aug 14, 2026 5:02 AM
ARS Pharmaceuticals Q2 Earnings Call Highlights
MarketBeat · Aug 14, 2026 3:04 AM
ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises
MT Newswires · Aug 13, 2026 9:40 PM
ARS Pharmaceuticals, Inc. (SPRY) Reports Q2 Loss, Tops Revenue Estimates
Zacks · Aug 13, 2026 9:35 PM
ARS Pharmaceuticals Outlines Strategic Priorities, including a Focused Commercial Strategy, and Reports Second Quarter 2026 Financial Results
GlobeNewswire · Aug 13, 2026 8:01 PM
What To Expect From ARS Pharmaceuticals Inc (SPRY) Q2 2026 Earnings
GuruFocus.com · Aug 12, 2026 1:24 PM
Financial Overview - Income Statement Quarterly

See SPRY's money flow as a full page

Social Sentiment
Avg +0.64 · 10 posts
DDNewsDiscussionPriceTargetARS Pharma (SPRY)—are the insiders right, or is the market right?
r/wallstreetbets · May 13, 2026
Insider selling is viewed negatively, but a drying up of sales combined with good news suggests a potential upward trend. The 'betting it will fall further' sentiment contrasts with the author's optimism.
positive +0.60
DDDiscussionI’m a nurse. And I love this product. I think this company is the next big thing.
r/wallstreetbets · Oct 13, 2025
The author strongly advocates for the company and highlights key product advantages.
very_positive +0.90
DDNewsDiscussion🚨 $AQST DD 🚨 Battle of the Drug Dealers: $AQST vs $SPRY vs Epipen (FDA Jan 31 Catalyst)
r/wallstreetbets · Sep 24, 2025
SPRY is actively discussed alongside AQST in the post.
positive +0.50
DDNewsTradeSPRY Gains
r/wallstreetbets · Feb 28, 2025
The post expresses a positive view of the stock due to favorable news and a low P/E ratio.
positive +0.60
DDNewsDiscussionARS Pharmaceuticals, Inc. (SPRY)
r/wallstreetbets · Oct 3, 2024
The post discusses the benefits and potential of SPRY's epinephrine nasal spray, presenting it as a favorable alternative to traditional EpiPens.
positive +0.60
Page 1 of 2 (10 total)
AI Analysis

Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.

Not financial advice. All data, scores, charts, and analysis on this site are provided for informational and educational purposes only and do not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. See our Legal Notice for full details.
An unhandled error has occurred. Reload 🗙